Find information on thousands of medical conditions and prescription drugs.

Clemastine

Clemastine is an over-the-counter antihistamine sold in the United States under the name Tavist. Although it is not a non-sedating antihistamine like loratadine or fexofenadine, it seems to have fewer side effects than most widely used "regular" antihistamines.

Home
Diseases
Medicines
A
B
C
Cabergoline
Caduet
Cafergot
Caffeine
Calan
Calciparine
Calcitonin
Calcitriol
Calcium folinate
Campath
Camptosar
Camptosar
Cancidas
Candesartan
Cannabinol
Capecitabine
Capoten
Captohexal
Captopril
Carbachol
Carbadox
Carbamazepine
Carbatrol
Carbenicillin
Carbidopa
Carbimazole
Carboplatin
Cardinorm
Cardiolite
Cardizem
Cardura
Carfentanil
Carisoprodol
Carnitine
Carvedilol
Casodex
Cataflam
Catapres
Cathine
Cathinone
Caverject
Ceclor
Cefacetrile
Cefaclor
Cefaclor
Cefadroxil
Cefazolin
Cefepime
Cefixime
Cefotan
Cefotaxime
Cefotetan
Cefpodoxime
Cefprozil
Ceftazidime
Ceftriaxone
Ceftriaxone
Cefuroxime
Cefuroxime
Cefzil
Celebrex
Celexa
Cellcept
Cephalexin
Cerebyx
Cerivastatin
Cerumenex
Cetirizine
Cetrimide
Chenodeoxycholic acid
Chloralose
Chlorambucil
Chloramphenicol
Chlordiazepoxide
Chlorhexidine
Chloropyramine
Chloroquine
Chloroxylenol
Chlorphenamine
Chlorpromazine
Chlorpropamide
Chlorprothixene
Chlortalidone
Chlortetracycline
Cholac
Cholybar
Choriogonadotropin alfa
Chorionic gonadotropin
Chymotrypsin
Cialis
Ciclopirox
Cicloral
Ciclosporin
Cidofovir
Ciglitazone
Cilastatin
Cilostazol
Cimehexal
Cimetidine
Cinchophen
Cinnarizine
Cipro
Ciprofloxacin
Cisapride
Cisplatin
Citalopram
Citicoline
Cladribine
Clamoxyquine
Clarinex
Clarithromycin
Claritin
Clavulanic acid
Clemastine
Clenbuterol
Climara
Clindamycin
Clioquinol
Clobazam
Clobetasol
Clofazimine
Clomhexal
Clomid
Clomifene
Clomipramine
Clonazepam
Clonidine
Clopidogrel
Clotrimazole
Cloxacillin
Clozapine
Clozaril
Cocarboxylase
Cogentin
Colistin
Colyte
Combivent
Commit
Compazine
Concerta
Copaxone
Cordarone
Coreg
Corgard
Corticotropin
Cortisone
Cotinine
Cotrim
Coumadin
Cozaar
Crestor
Crospovidone
Cuprimine
Cyanocobalamin
Cyclessa
Cyclizine
Cyclobenzaprine
Cyclopentolate
Cyclophosphamide
Cyclopropane
Cylert
Cyproterone
Cystagon
Cysteine
Cytarabine
Cytotec
Cytovene
Isotretinoin
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Read more at Wikipedia.org


[List your site here Free!]


Drugs, Pregnancy, And Lactation
From OB/GYN News, 6/1/01 by Gerald G. Briggs

Antihistamines comprise a large, fairly diverse group of compounds that are so prevalent that many women are probably exposed to these drugs at some point during pregnancy.

In general, first-generation antihistamines are usually safe during pregnancy when used occasionally, but should not be used for frequent, chronic allergy symptoms. There is little human pregnancy information on second-generation antihistamines.

During the first trimester, it is best to avoid antihistamines. But if an antihistamine is indicated, the best option is the oral first-generation drug chlorpheniramine, which is marketed over the counter under several names, including Chlor-Trimeton. If an injectable antihistamine is indicated, diphenhydramine (Benadryl)would be the first choice.

Most published data on antihistamine use during pregnancy concern these two drugs and indicate that they are relatively safe when used occasionally. There have been no signals or clusters of birth defects found in multiple studies of these agents.

The three second-generation antihistamines--cetirizine (Zyrtec), loratadine (Claritin), and fexofenadine (Allegra)--have not been shown to be teratogenic in animals. Nevertheless, they should be avoided if possible during the first trimester because of the sparse amount of data in humans on use of these drugs during pregnancy These data include a 1997 study of pregnant women that found no significant difference in the rates of major or minor malformations, gestational age at delivery, birth weight, or neonatal distress among 39 women who took cetirizine (most included first-trimester use), 81 women who took hydroxyzine (Vistaril or Atarax), and 110 controls who did not take either agent.

In a 1998 study of 18 women who took loratadine during the first trimester, 16 had normal infants with no major malformations; the other two had elective abortions. But this study is small and did not look for minor malformations. Loratadine is considered by many authors to be an acceptable alternative to a first-generation antihista mine, except during the first trimester.

To date, there have been no reports of human pregnancies exposed to Allegra, but problems with implantation have been reported in rats administered three times the human dose.

Neonatal withdrawal symptoms have been reported rarely in conjunction with commonly used antihistamines when used continuously during pregnancy, with the most cases reported for diphenhydramine. A woman who took 150 mg a day of diphenhydramine throughout pregnancy gave birth to a baby who developed withdrawal symptoms on the fifth day of life. Hydroxyzine has also been reported to cause withdrawal symptoms in newborns.

Diphenhydramine also has dose-related oxytocic properties and, if administered intravenously during labor, can stimulate the uterus.

A drug interaction between diphenhydramine (50 mg) and the sleeping medication temazepam (Restoril 30mg) may have led to the stillbirth of a term fetus. The mechanism of the interaction is unknown, but a high fetal death rate was confirmed in one animal study when the two drugs were combined.

A significantly increased risk of retrolental fibroplasia in premature babies whose mothers had taken a first-generation antihistamine during the last 2 weeks of gestation was also found in a 1986 multicenter study of premature newborns. This defect has not been re ported in full-term babies exposed to antihistamines in utero.

All antihistamines are excreted in breast milk, but there is little information on these drugs during lactation, particularly for second-generation agents.

Irritability and drowsiness in nursing infants are potential complications, and lactating mothers taking antihistamines should watch their infants for these ad verse effects. In one case with clemastine (Tavist), the infant also had neck stiffness and high-pitched crying.

In a study of loratadine, the drug and its metabolites were detected in the milk of six women who took four times the recommended dose. The author estimated that the infants received about 0.5% of their mother's total dose and concluded that there appeared to be little risk to the exposed infants. This was a one-time dose, and again, the message of this study is that occasion al use of these drugs during lactation does not seem to present a major risk, if any, but may cause problems when taken routinely.

GERALD G. BRIGGS is clinical pharmacist, Women's Hospital, Long Beach Memorial Medical Center; clinical professor of pharmacy, University of California, San Francisco.

COPYRIGHT 2001 International Medical News Group
COPYRIGHT 2001 Gale Group

Return to Clemastine
Home Contact Resources Exchange Links ebay